Validation of the Jawbone Anatomy Classification in Endosseous Dental Implant Treatment

The purpose of this study is to evaluate validation and clinical assessment of the earlier proposed clinical and radiological classification of the jawbone anatomy in endosseous dental implant treatment.

Expected results.

* high accuracy of proposed classification for proper implantation risk degree evaluation.
* the proposed classification system based on anatomical and radiological jawbone quantity and quality evaluation will be a helpful tool for planning of treatment strategy and collaboration among specialists.
* good interobserver reliability of clinical and radiological edentulous jaw segment evaluation.
* good reliability between radiological and intraoperative investigations and postoperative data.

The study aim.

to assess reliability and validity of the purposed jawbone anatomy clinical and radiological classification.

Objectives.

* risk degree evaluation for proper implantation.
* radiological edentulous jaw segment assessment according to study protocol for classification validation and reliability.
* intraoperative evaluation of surgery (dental implant placement if edentulous jaw segment (EJS) is type I or type II) according to study protocol: reliability of new proposed classification evaluation.
* postoperative radiological edentulous jaw segment evaluation for the accuracy of the classification identification.
* implant treatment success evaluation at final crown placement.

Object of the research.

partially edentulous patients referred to dentists and dental specialists with necessity of dental implant treatment.

Expected results.

* high accuracy of proposed classification for proper implantation risk degree evaluation.
* the proposed classification system based on anatomical and radiological jawbone quantity and quality evaluation will be a helpful tool for planning of treatment strategy and collaboration among specialists.
* good interobserver reliability of clinical and radiological edentulous jaw segment evaluation by the clinicians.
* good reliability between radiological and intraoperative investigations and postoperative data.

Granted Approvals.

* Kaunas Regional Biomedical Research Ethics Committee approval.
* State Data Protection Inspectorate approval.

Additional study quality factors.

* periodical sessions in the Clinic of Maxillofacial Surgery regard Phd studies intermediate results certification.
* periodical certification at the committee of PhD studies.

Patients sampling.

inclusion criteria fulfilled patients selection for dental implant treatment.

Size of the research. Patients referred to the dentists and dental specialists in Lithuania and other centers participating in the study.Total sample size is not less than 80 - 100 edentulous jaw segments. The duration of the study is one year of sample gathering (2014).

Material and methods. Dental notation: World Dental Association (FDI) dental notation system. The length measurement system is metric (millimetres with integer numbers according to the mathematical rules). Non linear measurements values are provided: "+" - agreement, "-" - disagreement. Separate stages of the study should be documented - digital pictures (under protocol requirements) should be taken.

The international study is based on classification (please find the first article in the list of publications). The investigation unit is edentulous jaw segment in aesthetic or non aesthetic zone. Aesthetic zone contains incisive, canine and premolar edentulous jaw segments. Molar region edentulous jaw segments belong to non aesthetic zone. The proposed classification accuracy is evaluated after edentulous jaw segment preoperative, intraoperative, early postoperative and late postoperative stages corresponding parameters comparison in the aesthetic and non aesthetic zone (the evaluation of the corresponding parameters are different at separate stages). The corresponding data collection in to appendices (Appendix 1, Appendix 2, Appendix 3) should be made by the calibrated and trained in the field investigator.

Study stages.

Preoperative stage.

1. Clinical facial preoperative image of defect area (approximately 4 teeth in the picture).
2. CBCT investigation.
3. EJS height evaluation (Appendix 1).
4. EJS width evaluation (Appendix 1).
5. EJS length evaluation (Appendix 1).
6. EJS Mandibular canal walls and jawbone quality evaluation (Appendix 1).
7. Planned dental implant (system), height, width (Appendix 1).
8. Overall EJS type (risk degree) (Appendix 1). Note: type III edentulous jaw segment should not be chosen for following steps evaluation because of high risk for implantation.

   Intraoperative stage.
9. Facial image with probe in the center of EJS before osteotomy.
10. Occlusal image with probe in the center of EJS before osteotomy.
11. EJS alveolar ridge vertical position evaluation (Appendix 2).
12. EJS mesial and distal interdental bone peak height evaluation in aesthetic zone (Appendix 2).
13. Implant threads coverage by the bone (Appendix 2).
14. Implant host sites bony walls fractures during drilling procedure or implant insertion (Appendix 2).
15. Primary implant stability at insertion (Appendix 2).
16. Excessive bleeding in the apical region of osteotomy (Appendix 2).
17. Mandibular canal perforation and inferior alveolar nerve direct mechanical injury by implant drill (Appendix 2).
18. Implant drill slippage deeper than planned (Appendix 2).
19. Implant placement deeper than planned (Appendix 2).
20. Placed dental implant parameters (length, width) (Appendix 2).
21. Facial image after dental implant placement.
22. Occlusal image after dental implant placement. Note: Following steps should not be performed if dental implant was not placed.

    Early postoperative stage.
23. EJS radiological investigation (periapical radiograph).
24. Distance from implant apex to anatomically important structures on periapical radiograph (Appendix 2).

    Late postoperative stage.
25. Facial image of defect area after healing period.
26. Occlusal image of defect area after healing period.
27. Facial image of defect area with implant long axis oriented periodontal probe in the region of adjacent tooth after final crown placement.
28. Occlusal image of defect area after final crown placement.
29. Vertical soft tissue deficiency evaluation (Appendix 3).
30. Interdental mesial and distal papillae appearance in aesthetic zone (Appendix 3).

Appendix 1. Implantation risk evaluation questionnaire

Observer:

Assessment series No:

Date:

The tooth was lost _ _ months/ _ _ year(s) before surgery

Patients name and family name:

Gender: Male □ Female □

Age:

Aesthetic zone Tooth No: 15 14 13 12 11 21 22 23 24 25 35 34 33 43 44 45 Non aesthetic zone tooth No: 17 16 26 27 37 36 46 47 Edentulous jaw segment parameters Edentulous jaw segment types (risk degree): Type I (low risk), Type II (moderate risk), Type III (high risk) Non aesthetic zone

Height (mm):

Maxilla \>10 □ \>8 to ≤10 □ ≤8 □ Maxillary sinus region \>10 □ \>4 to ≤10 □ ≤4 □ Mandible \>10 □ \>8 to ≤10 □ ≤8 □ Width (mm): \>6 □ \>4 to ≤ 6 □ \<4 □ Length (mm): ≥7 or ≤12 □ ≥6 or ≤13 □ \<6 or \>13 □ Aesthetic zone

Height (mm):

Maxilla \>10 □ \>8 to ≤10 □ ≤8 □ Maxillary sinus region \>10 □ \>4 to ≤10 □ ≤ 4 □ Mandible \>10 □ \>8 to ≤10 □ ≤8 □

Width (mm):

Optimal implant diameter + 3 □ Optimal implant diameter + \<3 □ Optimal implant diameter + ≤0 □ Length (mm) Equal to contralateral tooth □ Asymmetry \<1 mm with contralateral tooth □ Asymmetry ≥1 mm with contralateral tooth □ Mandibular canal (MC) region (inferior alveolar nerve injury risk degree) MC walls identification and jawbone quality type combination Identified MC walls/D2 and D3 □ Unidentified superior MC wall/D1 and D4 □ Unidentified MC/D1 and D4 □ Planned dental implant system (name) □ Dental implant: height (mm) □, width (mm) □ Implant surgery is not planned □ Overall EJS type (risk degree): Type I □ Type II □ Type III □

Appendix 2. Intraoperative evaluation of surgery and early postoperative stage evaluation questionnaire

Observer:

Assessment series No:

Date:

Patients name and family name:

Aesthetic zone tooth No: 15 14 13 12 11 21 22 23 24 25 35 34 33 43 44 45 Non aesthetic zone tooth No: 17 16 26 27 37 36 46 47 Overall planned edentulous jaw segment type (risk degree): I, II Intraoperative surgery evaluation parameters Agreement with implantation risk evaluation: No risk, Risk

Alveolar ridge vertical position (mm):

Non aesthetic zone ≤3 □ \>3 to \<7 □ ≥7 □ Aesthetic zone ≤1 □ \>1 to ≤3 □ \>3 □

Bone peak height (mm):

Mesial 3 to 4 □ \>1 to ≤3 □ \<1 □ Distal 3 to 4 □ \>1 to ≤3 □ \<1 □

Implant threads coverage by the bone (mm):

Non aesthetic zone ≥1 □ Implant walls are covered by the bone \<1 □ Cervical part(s) of the implant is not covered by the bone (dehiscence) □ Isolated implant part(s) is not covered by the bone (fenestration) □ Aesthetic zone (buccal + lingual wall ) ≥3 □ Total sum of implant coverage by the bone from buccal and lingual side \<3 □ Cervical part(s) of the implant is not covered by the bone (dehiscence) □ Isolated implant part(s) is not covered by the bone (fenestration) □

Implant host sites bony walls fractures:

not present □ present □

Primary implant stability (Ncm):

≥45 □ ≥15 to \<45 □ \<15 □

Excessive bleeding in the apical region of osteotomy:

not present □ present □

Mandibular canal perforation and inferior alveolar nerve direct mechanical injury by implant drill:

"sudden give" or "electric shock" has not appeared □ "sudden give" or "electric shock" has appeared □

Implant drill slippage deeper than planned:

not present □ present □

Implant placement deeper than planned:

not present □ present □

Placed dental implant:

height □ width □ dental implant was not placed □

Distance from implant apex to anatomically important vital structures (mm):

≥2 □ \<2 □

Appendix 3. Late postoperative stage parameters evaluation questionnaire

Observer:

Assessment series No:

Date:

Patients name and family name:

Aesthetic zone tooth No: 15 14 13 12 11 21 22 23 24 25 35 34 33 43 44 45 Non aesthetic zone tooth No: 17 16 26 27 37 36 46 47 Overall planned edentulous jaw segment type (risk degree): I, II Late postoperative evaluation parameters Agreement with intraoperative stage risk evaluation: No risk, Risk

Soft tissue vertical deficiency (mm):

0 □ 1 to 2 □ \>2 □

Papilla appearance (aesthetic zone parameter):

Mesial Complete fill □ Partial fill □ None □ Distal Complete fill □ Partial fill □ None □

Eligibility Criteria:
Inclusion Criteria:

1. general

   * systematically healthy (American Society of Anaesthesiologists I or II)
   * subject age 18 years or older women and men
   * availability of complete clinical records
   * compliance with all requirements in the study and signing the informed consent
   * absence of allergy to dental implants alloys
2. local

   * subjects have one or more single limited by neighbouring teeth from both sides edentulous jaw segment
   * the tooth was lost two months or earlier prior the study
   * adjacent edentulous jaw segments have no implant
   * adjacent teeth are intact or have all no defective restorations over cementoenamel junction
   * patient will not wear any kind of removable prosthesis over the treatment area

Exclusion Criteria:

1. local

   * acute infection at the region of edentulous jaw segment
   * active periodontal diseases
   * current orthodontic or periodontal treatments
   * heavy smokers (more than 10 cigarettes a day)
   * untreated teeth or defective restorations that can potentially exacerbate during the study
   * wisdom tooth edentulous jaw segment or edentulous jaw segment with unerupted tooth
   * central and lateral lower incisors edentulous jaw segments (individual case related treatment planning)
2. general:

   * pregnancy or lactating mothers
   * history of alcoholism or drug abuse
   * bone disorders (Paget's disease, osteoporosis, or hyperparathyroidism)
   * a history of intravenous (IV) bisphosphonate use
   * neurologic or psychiatric disorders, systemic infections
   * chronic use of medications known to affect the periodontal status (calcium antagonists, anticonvulsives, immunosuppressives, anti-inflammatory medications)
   * diseases of the immune system or any medical conditions that may influence the treatment outcome (e.g. uncontrolled diabetes)